Pseudobulbar Treatment Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030

The Global Pseudobulbar Treatment Market Size accounted for USD 2,761 Million in 2021 and will achieve a market size of USD 6,022 Million by 2030, budding at a CAGR of 9.4%.

Pseudobulbar affect (PBA) is a condition that's characterized by episodes of sudden uncontrollable and inappropriate laughing or crying. Pseudobulbar affect typically occurs in people with certain neurological conditions or injuries, which might affect the way the brain controls emotion. Increasing prevalence of pseudobulbar affect is the primary factor boosting the global pseudobulbar treatment market revenue. Furthermore, the increasing number of research and development activities is expected to be a prominent pseudobulbar treatment market trend fueling industry growth from 2022 to 2030.

Global Pseudobulbar Treatment Market DROs:

Drivers

• Surging prevalence of pseudobulbar affect
• Rise in initiatives to spread awareness related to the disease

Restraints

• High cost associated with the treatment
• Lack of qualified and skilled professionals

Opportunities

• Increasing investment for healthcare infrastructure
• Growing number of research & development activities

Report Coverage

PBA is affecting a large number of people across the globe. Pseudobulbar affect (PBA) is a condition that's characterized by episodes of sudden uncontrollable and inappropriate laughing or crying. It is witnessed among patients suffering from multiple sclerosis (MS), traumatic brain injury, and Alzheimer's disease. According to CDC, in 2020, as many as 5.8 million Americans were living with Alzheimer’s disease. In 2017, around 2 million people in the U.S. were suffering from pseudobulbar affect. Pseudobulbar affect is primarily associated with neurological disorders, and around 30% to 35% of patients suffer from depression. Prevalence of pseudobulbar affect is higher in people with neurological disorders, which is around 5% to 50%. A rapid increase in the number of patients suffering from PBA and increasing awareness among consumers related to the availability of advanced treatments are factors expected to drive the growth of the global pseudobulbar treatment market. Increasing R&D activities by major players rise in clinical trial activities for the development of new drugs, and approvals from the regulatory bodies are factors expected to segment the growth of the pseudobulbar treatment market.

Favorable business policies by the government and the emergence of small & Mid-size enterprises with innovative solutions are factors expected to boost the target market growth. Factors such as high costs associated with R&D activities of drugs and strict government regulations related to product approval are expected to hamper the growth of the global pseudobulbar treatment market. In addition, the lack of developed infrastructure in developing countries for R&D activities is expected to challenge the growth of the target market. However, huge investment by manufacturers for drug discovery and inclination towards tracking the untapped market in developing regions are factors expected to create new opportunities for players operating in the pseudobulbar treatment market over the forecast period. In addition, the government of developing countries focus on strengthening the regional manufacturing capabilities is expected to attract players further responsible for the revenue growth of the market.

Pseudobulbar Treatment Market Segmentation

The global pseudobulbar treatment market is segmented into treatment, drugs, route of administration, and end-user. The treatment segment is divided into medication, supportive care, and others. The drug segment is bifurcated into pseudobulbar treatments, tricyclic antidepressants, nuedexta, and others. Among drugs, the tricyclic antidepressants segment is expected to witness faster growth in the target market.

Market by Drugs

• Pseudobulbar Treatments
• Tricyclic Antidepressants
• Nuedexta
• Others

Market by Treatment

• Medications
• Supportive Care
• Others

Market By Route of Administration

• Oral
• Parenteral
• Others

Market By End-Users

• Hospitals
• Specialty Clinics
• Others

Pseudobulbar Treatment Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America

• Mexico
• Brazil
• Rest of Latin America

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

The Middle East & Africa (MEA)

• Gulf Cooperation Council (GCC)
• South Africa
• Rest of the Middle East & Africa